A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
Surfactant protein B (SPB) deficiency is a severe monogenic interstitial lung disorder that leads to loss of life in infants as a result of alveolar collapse and respiratory distress syndrome. The development and assessment of curative therapies for the deficiency are limited by the general lack of...
Autores principales: | Munis, AM, Hyde, SC, Gill, DR |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Ejemplares similares
-
A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
por: Altar M. Munis, et al.
Publicado: (2021-03-01) -
RNA-Seq analysis of the human surfactant air-liquid interface culture reveals alveolar Type II cell-like transcriptome
por: Munis, AM, et al.
Publicado: (2021) -
Gene therapy for surfactant protein B deficiency using recombinant AAV
por: Meyer-Berg, H, et al.
Publicado: (2019) -
The influence of sorbitol on the adsorption of surfactants at the air-liquid interface
por: Staples, E, et al.
Publicado: (1996) -
Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
por: Sergijenko, A, et al.
Publicado: (2021)